Business Context and Reporting Period
Company: ONTO INNOVATION INC.
Filing Type: Form 10-Q (Unaudited)
Reporting Period: Three months ended March 31, 2026 (Q1 2026)
Business Overview: Onto Innovation designs, develops, and manufactures process control tools for semiconductor and advanced packaging device manufacturers. The company operates as a single reportable segment.
Fiscal Year Change: The Company changed its fiscal year-end from a 52-53 week year to a calendar year (December 31) effective with this reporting period.
Key Financial Metrics
| Metric (in thousands) | Q1 2026 | Q1 2025 |
|---|---|---|
| Revenue | $291,949 | $266,607 |
| Gross Profit | $146,389 | $143,233 |
| Gross Margin | 50.1% | 53.7% |
| Operating Income | $33,514 | $63,134 |
| Net Income | $33,750 | $64,095 |
| Diluted EPS | $0.67 | $1.30 |
| Cash from Operations | $26,322 | $91,980 |
| Cash & Marketable Securities | $654,164 | $203,727 (End of Q1 2025) |
Material Changes vs. Prior Period
- Revenue Growth: Revenue increased 9.5% year-over-year to $291.9 million, driven by $27.1 million in revenue from the acquired Semilab USA business and higher sales to logic and memory customers.
- Profitability Decline: Net income decreased 47% to $33.8 million. Operating income dropped 47% to $33.5 million.
- Expense Increases:
- Amortization: Increased to $19.7 million from $8.4 million due to the full quarter of Semilab USA intangible asset amortization.
- Restructuring: Restructuring and other expenses rose to $5.2 million (operating) and $10.2 million (COGS) from $1.1 million and $3.6 million, respectively, due to inventory write-downs and severance costs.
- R&D and G&A: R&D expenses increased 25% to $35.1 million; G&A increased 38% to $31.4 million, primarily due to headcount increases and integration costs.
- Cash Flow: Operating cash flow decreased significantly to $26.3 million from $92.0 million, attributed to timing of receivables and higher inventory levels. Investing activities used $112.6 million, primarily for purchasing marketable securities.
Guidance, Outlook, and Risks
- Strategic Acquisition (Rigaku): On April 20, 2026, the Company entered into an agreement to acquire a 27% stake in Rigaku Holdings Corporation for approximately $710 million. The transaction is expected to close in H2 2026.
- Financing: To fund the Rigaku transaction, the Company secured a $500 million bridge term loan credit facility with Goldman Sachs Bank USA.
- Share Repurchases: No shares were repurchased under the $200 million authorization during Q1 2026. Approximately $99.9 million remains available.
- Risks:
- Completion of the Rigaku transaction is subject to regulatory approvals and closing conditions.
- Integration risks associated with the Semilab USA acquisition.
- Geopolitical conflicts and trade policy changes affecting global operations.
- Dependence on significant customers (Customer A, B, and C each accounted for >10% of revenue).
Investor Verification Checklist
- Acquisition Integration: Verify the progress of Semilab USA integration and the realization of projected synergies.
- Rigaku Transaction Status: Monitor regulatory approval timelines and the final closing of the $710 million Rigaku investment.
- Debt Obligations: Review the terms and repayment schedule of the new $500 million bridge loan.
- Inventory Levels: Assess the impact of recent inventory write-downs and step-up amortization on future margins.
- Customer Concentration: Track revenue stability from top customers (Customer A, B, C) given their significant share of total revenue.